Komal Sawlani, MD
Specialty
Neurology, Neurology-Neuromuscular Medicine
Accepting New Patients
Schedule an Appointment
Biography
- Program Director, Neuromuscular Medicine, UH Cleveland Medical Center
- Assistant Professor, CWRU School of Medicine
Expertise
- Amyotrophic Lateral Sclerosis (ALS)
- Carpal Tunnel Syndrome
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Electromyography (EMG)
- Entrapment Neuropathies
- Myasthenia Gravis (MG)
- Myopathies
- Nerve Conduction Studies (NCS)
- Peripheral Neuropathies
- Ulnar Neuropathies
Languages Spoken
English, French
Office Locations
UH Minoff Health Center at Chagrin Highlands
3909 Orange Pl
Beachwood, OH 44122
216-844-2724
Patient Experience Reviews
4.6 out of 5
37 Ratings
Patient Comments (6)
Reviewed On 4/1/2023
Excellent Doctor. ***
Reviewed On 12/1/2022
She is the best. She took care of me the whole time and never let me down. She's very good.
Reviewed On 12/1/2022
Dr Sawlani was, as always, very patient and thorough during our meeting. She and her assistant performed all of the tests for my strength or lack thereof due to *** and answered all of my questions about my condition and about another medical question I had about Covid.
Reviewed On 11/1/2022
Very very helpful showed real concern. Felt very good after visit.
Reviewed On 9/2/2022
She is very caring doctor, so glad to be in her care.
Reviewed On 9/2/2022
Very good
Research & Publications
Research Interests
Neuromuscular Disorders, Amyotrophic Lateral Sclerosis, EMG and Nerve conduction studies, Spinal muscular atrophy, Myasthenia Gravis
Certifications & Memberships
- Neuromuscular Medicine - American Board of Psychiatry and Neurology
- Neurology - American Board of Psychiatry and Neurology
Education
Fellowship | Neuromuscular Disease
Neuromuscular Disease - Brigham And Women's Hospital (2015 - 2016)
Residency | Neurology
Neurology - Uh Case Medical Center (2011 - 2015)
Medical Education
Indiana University School Of Medicine (2011)
Undergraduate
Northwestern University (2007)
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Komal Sawlani did not disclose any Outside Relationships with Industry.